T1	HMM 299 310	vision loss
T2	HMM 549 558	Biosafety
T3	HMM 1019 1090	Treatment-emergent adverse events including blood chemistry metabolites
T4	HMM 1125 1184	supplementation elevated plasma and red blood cell-DHA 4.4-
T5	HMM 1354 1471	for vitamin A, vitamin E, platelet aggregation, antioxidant activity, lipoprotein cholesterol, or oxidized LDL levels
T6	HMM 1481 1487	0.14).
T7	HMM 1488 1502	Adverse events
T8	HMM 1518 1543	and not considered severe
T9	HMM 1548 1549	.
T10	HMM 1551 1615	gastrointestinal [GI] irritability, blood chemistry alterations)
T11	HMM 1647 1680	tolerate persistent GI discomfort
T12	HMM 1772 1797	with limited safety risks
T13	HMM 1820 1845	Nevertheless, GI symptoms
